Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Toronto

$25,000.00

Analysis of brain microcircuitry with statistical physics and machine learning tools

FY 2018-19

Summary
Approximately one in every five people will suffer from a mental health or a neurological condition during*their life time. Due to the enormous complexity of the nervous system, understanding the underlying cellular*mechanisms of diseases such as dementia, epilepsy, depression and bipolar disorder has proven to be a*challenging task. To understand the underlying causes of brain and spinal cord diseases, the next generation of*diagnostic imaging technologies will need to provide more detailed understanding of how distinct types of*neurons in different regions of the brain and the spinal cord work together to encode, regulate, process and*transfer information within the nervous system. In the past two decades, functional imaging technologies, such*as fMRI and PET have provided a significant improvement in our understanding of the brain function.*However, these methods and current optical devices do not allow simultaneous monitoring of activities of*individual neurons in large neuronal assemblies in multiple regions that are involved in a disease and are*located deep in the brain and in the spinal cord. Neurescence, a Canadian owned and operated company, is the*only company in the market that offers the capability of simultaneously monitoring the activities of neuronal*populations in multiple brain and spinal cord regions, with its first available product called Quartet. The*novelty of Quartet technology requires appropriate new tools for the analysis of the data it provides to yield the*most significant insight into brain function. With these new tools, Neurescence platform enables better*understanding of the system level operation of the central nervous system and leveraging this understanding*for rational drug development. In this proposal we will apply recently developed machine learning tools rooted*in statistical physics to the analysis of the data obtained by Quartet and will develop efficient inference and*analysis venues with the overarching goal of integrating the mathematical analysis into a software-hardware*package for Neurescence. This addition to Neurescence's product line allows employment of additional highly*qualified personnel and contribute to the Canadian economy.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
522729-2018
Name nom
Zilman, Anton
Department département
Physics (St. George Campus)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3113
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biophysics
Research subject fr
Biophysique
Partie
1
Nb partie
1
Application title
Analysis of brain microcircuitry with statistical physics and machine learning tools
Keyword
NSERC
Application summary
Approximately one in every five people will suffer from a mental health or a neurological condition during*their life time. Due to the enormous complexity of the nervous system, understanding the underlying cellular*mechanisms of diseases such as dementia, epilepsy, depression and bipolar disorder has proven to be a*challenging task. To understand the underlying causes of brain and spinal cord diseases, the next generation of*diagnostic imaging technologies will need to provide more detailed understanding of how distinct types of*neurons in different regions of the brain and the spinal cord work together to encode, regulate, process and*transfer information within the nervous system. In the past two decades, functional imaging technologies, such*as fMRI and PET have provided a significant improvement in our understanding of the brain function.*However, these methods and current optical devices do not allow simultaneous monitoring of activities of*individual neurons in large neuronal assemblies in multiple regions that are involved in a disease and are*located deep in the brain and in the spinal cord. Neurescence, a Canadian owned and operated company, is the*only company in the market that offers the capability of simultaneously monitoring the activities of neuronal*populations in multiple brain and spinal cord regions, with its first available product called Quartet. The*novelty of Quartet technology requires appropriate new tools for the analysis of the data it provides to yield the*most significant insight into brain function. With these new tools, Neurescence platform enables better*understanding of the system level operation of the central nervous system and leveraging this understanding*for rational drug development. In this proposal we will apply recently developed machine learning tools rooted*in statistical physics to the analysis of the data obtained by Quartet and will develop efficient inference and*analysis venues with the overarching goal of integrating the mathematical analysis into a software-hardware*package for Neurescence. This addition to Neurescence's product line allows employment of additional highly*qualified personnel and contribute to the Canadian economy.